Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

STRATA Skin Sciences (SSKN) Non-Current Assets (2016 - 2025)

STRATA Skin Sciences' Non-Current Assets history spans 15 years, with the latest figure at $1.3 million for Q4 2025.

  • On a quarterly basis, Non-Current Assets changed 0.0% to $1.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $1.3 million, a 0.0% change, with the full-year FY2025 number at $1.3 million, changed 0.0% from a year prior.
  • Non-Current Assets hit $1.3 million in Q4 2025 for STRATA Skin Sciences, up from $1.2 million in the prior quarter.
  • Over the last five years, Non-Current Assets for SSKN hit a ceiling of $36.0 million in Q1 2022 and a floor of $600000.0 in Q4 2022.
  • Historically, Non-Current Assets has averaged $17.7 million across 5 years, with a median of $22.6 million in 2021.
  • Biggest five-year swings in Non-Current Assets: skyrocketed 100.0% in 2021 and later tumbled 95.38% in 2025.
  • Tracing SSKN's Non-Current Assets over 5 years: stood at $1.0 million in 2021, then tumbled by 40.0% to $600000.0 in 2022, then soared by 33.33% to $800000.0 in 2023, then soared by 62.5% to $1.3 million in 2024, then changed by 0.0% to $1.3 million in 2025.
  • Business Quant data shows Non-Current Assets for SSKN at $1.3 million in Q4 2025, $1.2 million in Q3 2025, and $1.2 million in Q2 2025.